of borderline significanceP = 0.0666
4B ) showed a significant increase with duration of treatment ( P = 0.0217), a dose response of borderline significance ( P = 0.0666), and an increase in mutation counts with longer duration treatment of borderline significance ( P = 0.0688, not shown).